Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
News Release
Enlyte Announces Its 2024 Heart of Case Management Award Winners
Honorees represent the best of those who make a profound impact on the lives of employees with injuries and disabilitiesS
WorkCompCentral
In the News
Enlyte Launches Physical Medicine Network
Business Insurance
In the News
Enlyte launches specialty service for injured workers
Workers' Comp
News Release
Enlyte Launches Apricus Physical Medicine, Offering End-to-End Specialty Service Solution for Industry
New program introduces comprehensive rehabilitative services with integrated clinical oversight and continuous care coordination
Auto Casualty
Article
Balanced Regulatory Environment: A Key Component to Unlocking the Value of Specialty Bill Review
Without the use of Specialty Bill Review (SBR), payers risk paying for errors or abuses created by providers with problematic billing practices.
Workers' Comp
Article
Ask The Pharmacist: Understanding Skeletal Muscle Relaxants in Workers' Compensation
What should I know about skeletal muscle relaxants in the treatment of injuries? Skeletal muscle relaxants a